An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers market the substance there before directing buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting products of unknown origin.
Some experts stated the popularity for the experimental drug could be connected to the increasing price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach medicines, marketing, and consumer laws, risking fines, legal action or prison.
Service Reaction and Material Removal
Based on the social media company, the service has removed violative content and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, filled with images of weight loss, glowing testimonials and detailed guides for mixing or administering at home.
Within moments of joining one community, a seller posted contact information, where most purchases take place. The vendor provided an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these communities, posts display black plastic packages with Royal Mail labels, claiming to include new batches. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to potentially serious medical dangers”.
